Preventing stroke: A review of current guidelines

Journal of the American Medical Directors Association

Volumn 4, Issue 5 SUPPL., 2003, Pages

  Akopov, Sergey ^a   Cohen, Stanley N ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ATENOLOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; LOSARTAN; NICOTINIC ACID; PERINDOPRIL; PRAVASTATIN; RAMIPRIL; RESIN; SIMVASTATIN; TICLOPIDINE; WARFARIN;

BEHAVIOR MODIFICATION; BODY WEIGHT; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIABETES MELLITUS; DIARRHEA; DIETARY INTAKE; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMOLYTIC UREMIC SYNDROME; HIGH RISK PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; LIFESTYLE; MALE; MORTALITY; NEUTROPENIA; OBESITY; PHYSICAL ACTIVITY; PRACTICE GUIDELINE; RASH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING CESSATION; STROKE; THROMBOTIC THROMBOCYTOPENIC PURPURA; WEIGHT REDUCTION;

EID: 0141744646     PISSN: 15258610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-8610(04)70385-0     Document Type: Article

References (13)

1. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001;32:280-299.
2. Pearson TA, Blair SN, Daniels SR, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 Update: Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002;106:388-391.
3. Gorelick PB, Mazzone T. Plasma lipids and stroke. J Cardiovasc Risk 1999;6:217-221.
4. Amarenco P. Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction. Neurology 2001;57(suppl 2):S35-S44.
5. Gorelick PB. Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy: An invited review. Stroke 2002;33:862-875.
6. Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention. JAMA 2002;288:1388-1395.
7. Cohen SN. Antiplatelet therapy to prevent ischemic stroke. Fed Pract 2001;18:46-57.
8. Hart RG, Bailey RD. An assessment of guidelines for prevention of ischemic stroke. Neurology 2002;59:977-982.
9. Albers GW, Amarenco P, Easton JD, et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001;119(suppl 1):300S-320S.
10. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomized controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 2003;361:107-116.
11. Alamowitch S, Eliasziw M, Algra A, et al. Risk, causes, and prevention of ischemic stroke in elderly patients with symptomatic internal carotid artery stenosis. Lancet 2001;357:1156-1160.
12. Albers GW, Dalen JE, Laupacis A, et al. Antithrombotic therapy in atrial fibrillation. Sixth ACCP Consensus Conference on Antithrombotic Therapy. Chest 2001;119(suppl 1):194S-206S.
13. Man-Son-Hing M, Nichol G, Lau A, et al. Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls. Arch Intern Med 1999;159:677-685.